These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1710187)

  • 1. The central pressor actions of a novel tachykinin peptide, gamma-preprotachykinin-(72-92)-peptide amide.
    Hagio T; Takano Y; Nagashima A; Nakayama Y; Tateishi K; Kamiya H
    Eur J Pharmacol; 1991 Jan; 192(1):173-6. PubMed ID: 1710187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracerebroventricular responses to neuropeptide gamma in the conscious rat: characterization of its receptor with selective antagonists.
    Picard P; Couture R
    Br J Pharmacol; 1996 Jan; 117(2):241-9. PubMed ID: 8789375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of central tachykinin peptides in cardiovascular regulation in rats.
    Takano Y; Nagashima A; Hagio T; Tateishi K; Kamiya H
    Brain Res; 1990 Oct; 528(2):231-7. PubMed ID: 1703026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diverse effects of tachykinins on luteinizing hormone release in male rats: mechanism of action.
    Kalra PS; Sahu A; Bonavera JJ; Kalra SP
    Endocrinology; 1992 Sep; 131(3):1195-201. PubMed ID: 1380435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular responses to intrathecal neuropeptide gamma in conscious rats: receptor characterization and mechanism of action.
    Poulat P; de Champlain J; Couture R
    Br J Pharmacol; 1996 Jan; 117(2):250-7. PubMed ID: 8789376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular and behavioural effects of centrally administered tachykinins in the rat: characterization of receptors with selective antagonists.
    Picard P; Regoli D; Couture R
    Br J Pharmacol; 1994 May; 112(1):240-9. PubMed ID: 7518304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ventilatory and cardiovascular actions of centrally administered trout tachykinins in the unanesthetized trout.
    Le Mével JC; Lancien F; Mimassi N; Conlon JM
    J Exp Biol; 2007 Sep; 210(Pt 18):3301-10. PubMed ID: 17766308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the central tachykinin receptor subclass involved in substance P-induced cardiovascular and behavioral responses in conscious rats.
    Itoi K; Tschöpe C; Jost N; Culman J; Lebrun C; Stauss B; Unger T
    Eur J Pharmacol; 1992 Sep; 219(3):435-44. PubMed ID: 1385176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tachykinin receptor subtype. Central cardiovascular regulation of tachykinin peptides.
    Takano Y; Nagashima A; Hagio T; Nakayama Y; Kamiya H
    Ann N Y Acad Sci; 1991; 632():476-8. PubMed ID: 1719908
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of NK-1 receptor in central cardiovascular regulation in rats: studies on a novel non-peptide antagonist, CP-96,345, of substance P NK-1 receptor.
    Saigo A; Takano Y; Saito R; Nakayama Y; Honda K; Kamiya H
    Regul Pept; 1993 Jul; 46(1-2):293-6. PubMed ID: 7692520
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of NK-1 receptor in central cardiovascular regulation in rats: studies on a novel non-peptide antagonist, CP-96,345, of substance P NK-1 receptor.
    Takano Y; Nakayama Y; Tateishi K; Saito R; Kamiya H
    Neurosci Lett; 1992 May; 139(1):122-5. PubMed ID: 1328962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of selective antagonists to dissociate the central cardiovascular and behavioural effects of tachykinins on NK1 and NK2 receptors in the rat.
    Tschöpe C; Picard P; Culman J; Prat A; Itoi K; Regoli D; Unger T; Couture R
    Br J Pharmacol; 1992 Nov; 107(3):750-5. PubMed ID: 1335337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central tachykinin NK3 receptors in the inhibitory action on the rat colonic propulsion of a new tachykinin, PG-KII.
    Broccardo M; Improta G; Tabacco A
    Eur J Pharmacol; 1999 Jul; 376(1-2):67-71. PubMed ID: 10440091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. gamma-Preprotachykinin-(72-92)-peptide amide potentiates substance P-induced salivation.
    Takeda Y; Krause JE
    Eur J Pharmacol; 1989 Feb; 161(2-3):267-71. PubMed ID: 2470599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of SR 142801, a new potent non-peptide NK3 receptor antagonist on cardiovascular responses in conscious guinea-pig.
    Roccon A; Marchionni D; Nisato D
    Br J Pharmacol; 1996 Jul; 118(5):1095-102. PubMed ID: 8818331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasopressin release induced by intracranial injection of tachykinins is due to activation of central neurokinin-3 receptors.
    Polidori C; Saija A; Perfumi M; Costa G; de Caro G; Massi M
    Neurosci Lett; 1989 Sep; 103(3):320-5. PubMed ID: 2478934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological characterization of the pressor response to tachykinins in isolated perfused rat kidney.
    Chen Y; Hoover DB
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1176-80. PubMed ID: 7505328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral cardiovascular effects of tachykinins in conscious freely moving spontaneously hypertensive and Wistar Kyoto rats.
    Pompei P; Tayebaty SJ; Massi M; de Caro G
    Pharmacol Res; 1992; 25 Suppl 1():67-8. PubMed ID: 1380705
    [No Abstract]   [Full Text] [Related]  

  • 19. Central pressor actions of neurokinin B: increases in neurokinin B contents in discrete nuclei in spontaneously hypertensive rats.
    Nagashima A; Takano Y; Tateishi K; Matsuoka Y; Hamaoka T; Kamiya H
    Brain Res; 1989 Oct; 499(1):198-203. PubMed ID: 2478257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular responses to intravenous administration of human hemokinin-1 and its truncated form hemokinin-1(4-11) in anesthetized rats.
    Kong ZQ; Fu CY; Chen Q; Wang R
    Eur J Pharmacol; 2008 Aug; 590(1-3):310-6. PubMed ID: 18582457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.